Dinani apa ngati iyi ndi nkhani yanu yosindikiza!

Chithandizo Chatsopano cha Plaque Psoriasis

Written by mkonzi

Sun Pharma Canada Inc., kampani yothandizirana ndi Sun Pharmaceuticals Industries Limited (Sun Pharma) kuphatikiza mabungwe ake ndi/kapena makampani ogwirizana nawo) yalengeza PrILUMYA™ (jekeseni wa tildrakizumab), chithandizo kwa achikulire omwe ali ndi psoriasis yoyipa kwambiri, tsopano ikupezeka ku Canada.

Sangalalani, PDF ndi Imelo

"Ndife okondwa kuyambitsa chithandizo chofunikira chachilengedwechi kwa anthu aku Canada omwe ali ndi matendawa, oletsa komanso omwe nthawi zambiri amanyalanyazidwa. Kukhazikitsa uku ndi gawo lofunika kwambiri kwa Sun Pharma, pamene tikukulitsa mbiri yathu ya dermatology ku Canada, "atero Abhay Gandhi, CEO North America, Sun Pharma. "Pokhala ndi zaka zisanu zochiritsira zolimbitsa thupi zolimbitsa thupi, ILUMYA ikuwonetsa kudzipereka kwathu popereka mankhwala atsopano kuti athandizire moyo wa odwala komanso kusankha kwa dokotala."

Plaque psoriasis ndi matenda a autoimmune omwe amawoneka pakhungu ngati ofiira, okwera pakhungu omwe amakhala ndi mamba oyera omwe amatha kusweka ndikutuluka magazi. Zimakhudza pafupifupi anthu miliyoni aku Canada. Psoriasis yapakatikati mpaka yowopsa imakhudza pafupifupi 35% ya odwala. Vuto lalikulu ndilakuti mankhwala ambiri amasiya kugwira ntchito nthawi yayitali ndipo zizindikiro zimayambiranso. Kukhalitsa kwa chithandizo kwa nthawi yayitali ndikofunikira kwa odwala ambiri.

Dr. Melinda Gooderham, dokotala wodziwika bwino wa Dermatologist ndi Medical Director, Dr. Melinda Gooderham, anati: ku SKiN Center for Dermatology ku Peterborough, Ontario. "Odwala athu amafunikira njira zothandizira, zokhazikika komanso zopitilira muyeso ku Canada ndipo ILUMYA ithandiza kuthana ndi vutoli."

M'magazini yofalitsidwa ndi anzawo a kusanthula kophatikizidwa kwa mayesero awiri a reSURFACE 1 ndi reSURFACE 2, deta ikuwonetsa kuti odwala ambiri pa ILUMYA adasungabe kuyankha komanso mbiri yolimbikitsa ya chitetezo pazaka 5 za chithandizo.

Odwala omwe amathandizidwa ndi ILUMYA 100 mg, pafupifupi asanu ndi anayi mwa 10 adasunga yankho lawo kupyolera mu Chaka cha 5. ILUMYA 100 mg inaloledwa bwino pa mayesero a Phase 3. Zotsatira zoyipa zitatu zomwe zidachitika pafupipafupi kuposa placebo ndi ≥1% m'mayesero azachipatala zinali matenda opumira apamwamba (15.1% vs. 12.3%), zochitika zamalo a jekeseni (3.9% vs. 2.6%) ndi mutu (3.2% vs. 2.9%). ).

Ku Canada, odwala ena omwe adachita nawo kafukufukuyu akuti akadali ndi khungu loyera zaka zisanu ndi zitatu pambuyo pake.

"Ndili ndi odwala omwe akhala akuthandizidwa ndi ILUMYA kwa zaka zisanu ndi zitatu zapitazi, ndipo ndawonapo khungu lawo likuyenda bwino mpaka kufika pamtunda wapamwamba, ndikukhalabe bwino kwa nthawi yaitali. Chifukwa cha zimenezi, moyo wawo nawonso wapita patsogolo,” anawonjezera motero Dr. Gooderham.

“Moyo wanga wonse ndinkalimbana ndi matenda a plaque psoriasis, ndipo nthawi zonse ndinkasinthasintha pakati pa mafuta odzola ndi mafuta omwe sankagwira ntchito ndipo ankangowonjezera nkhawa. Mpaka nditaphunzira za ILUMYA, ndimaganiza kuti ndatha njira zachipatala, "atero Ainsley Leween, wodwala psoriasis. "Chiyambireni kugwiritsa ntchito ILUMYA zaka zisanu ndi zitatu zapitazo, psoriasis yanga yakhala ikuwongolera."

Canadian Agency for Drugs and Technologies in Health (CADTH), kudzera mu Common Drug Review, yalimbikitsa bwino zigawo zomwe zimagwira ntchito kuti mankhwala a ILUMYA abwezedwe kwa odwala omwe ali ndi plaque psoriasis ya moderate-to-severe plaque psoriasis, atauzidwa ndi dermatologist.

Sangalalani, PDF ndi Imelo

Ponena za wolemba

mkonzi

Mkonzi wamkulu ndi Linda Hohnholz.

Siyani Comment